参考文献/References:
[1] HOWARD R,KALES H C.New treatments for Alzheimer's disease[J].BMJ,2023,382:1852.
[2] KNAPSKOG A B,ENGEDAL K,SELBAK G,et al.Alzheimer's disease-diagnosis and treatment[J].Tidsskr Nor Laegeforen,2021,141(7):1-5.
[3] 刘伟,吴鸿波,杨红秀,等.β淀粉样蛋白对缺氧缺血性脑损伤新生鼠神经元凋亡影响的实验研究[J].陕西医学杂志,2024,53(4):462-467.
[4] 胡杨,彭茜,王倩,等.小热休克蛋白与阿尔茨海默病病理机制的研究进展[J].中华老年心脑血管病杂志,2020,22(9):1004-1006.
[5] CHEN X,SHI C,HE M,et al.Endoplasmic reticulum stress:Molecular mechanism and therapeutic targets[J].Signal Transduct Target Ther,2023,8(1):352.
[6] GOSWAMI P,AKHTER J,MANGLA A,et al.Downregulation of ATF-4 attenuates the endoplasmic reticulum stress-mediated neuroinflammation and cognitive impairment in experimentally induced Alzheimer's disease model[J].Mol Neurobiol,2024,61(8):5071-5082.
[7] DURAN-ANIOTZ C,POBLETE N,RIVERA-KRSTULOVIC C,et al.The unfolded protein response transcription factor XBP1s ameliorates Alzheimer's disease by improving synaptic function and proteostasis[J].Mol Ther,2023,31(7):2240-2256.
[8] SONG Z,WANG K W,HAGAR H C,et al.Hyperphosphorylated tau inflicts intracellular stress responses that are mitigated by apomorphine[J].Mol Neurobiol,2023,17(13):540661.
[9] SUZUKI M,TEZUKA K,HANDA T,et al.Upregulation of ribosome complexes at the blood-brain barrier in Alzheimer's disease patients[J].J Cereb Blood Flow Metab,2022,42(11):2134-2150.
[10] ZHANG X W,ZHU X X,TANG D S,et al.Targeting autophagy in Alzheimer's disease:Animal models and mechanisms[J].Zool Res,2023,44(6):1132-1145.
[11] 姜明贺,张鼎,朱欢欢,等.温肺降浊方对血管性痴呆大鼠海马神经元的作用机制[J].陕西中医,2024,42(3):291-296.
[12] 贾建平,王舒衡.阿尔茨海默病发病机制及治疗进展[J].中风与神经疾病杂志,2023,40(5):387-390.
[13] JIA J,NING Y,CHEN M,et al.Biomarker changes during 20 years preceding Alzheimer's disease[J].N Engl J Med,2024,390(8):712-722.
[14] 康涛,朱利娟,曹冰清,等.甲状腺激素受体β基因对β淀粉样蛋白42诱导的小胶质细胞炎症和细胞凋亡作用机制[J].陕西医学杂志,2021,50(10):1204-1209.
[15] GUO L,LI X,GOULD T,et al.T cell aging and Alzheimer's disease[J].Front Immunol,2023,14:1154699.
[16] GOPANENKO A V,MALYGIN A A,TUPIKIN A E,et al.Human ribosomal protein eS1 is engaged in cellular events related to processing and functioning of U11 snRNA[J].Nucleic Acids Res,2017,45(15):9121-9137.
[17] ZHOU C,WENG J,LIU C,et al.High RPS3A expression correlates with low tumor immune cell infiltration and unfavorable prognosis in hepatocellular carcinoma patients[J].Am J Cancer Res,2020,10(9):2768-2784.
[18] RUSSELL L,NAORA H,NAORA H.Down-regulated RPS3a/nbl expression during retinoid-induced differentiation of HL-60 cells:A close association with diminished susceptibility to actinomycin D-stimulated apoptosis[J].Cell Struct Funct,2000,25(2):103-113.
[19] TAO Y,HAN Y,YU L,et al.The predicted key molecules,functions,and pathways that bridge Mild Cognitive Impairment(MCI)and Alzheimer's Disease(AD)[J].Front Neurol,2020,11:233.
[20] 郭粉娥,李世英,郝乃猛.藏红花素调控Nrf2/HO-1通路改善血管性认知障碍大鼠学习记忆能力实验研究[J].陕西中医,2022,43(11):1516-1520.
[21] DE NECOCHEA-CAMPION R,GHOCHIKYAN A,JOSEPHS S F,et al.Expression of the epigenetic factor BORIS(CTCFL)in the human genome[J].Journal of Translational Medicine,2011,9:213.
[22] DAVIDSON I F,BARTH R,ZACZEK M,et al.CTCF is a DNA-tension-dependent barrier to cohesin-mediated loop extrusion[J].Nature,2023,616(7958):822-827.
[23] NISHANA M,HA C,RODRIGUEZ-HERNAEZ J,et al.Defining the relative and combined contribution of CTCF and CTCFL to genomic regulation[J].Genome Biol,2020,21(1):108.
[24] DEBAUGNY R E,SKOK J A.CTCF and CTCFL in cancer[J].Curr Opin Genet Dev,2020,61:44-52.
[25] PATEL P J,REN Y,YAN Z.Epigenomic analysis of Alzheimer's disease brains reveals diminished CTCF binding on genes involved in synaptic organization[J].Neurobiol Dis,2023,184:106192.